News Snapshot:
Share on WhatsApp Beijing: China approved Thursday its first COVID-19 vaccine for general public use. The COVID-19 vaccine shot has been developed by an affiliate of state-backed pharmaceutical giant Sinopharm. Sources said that Beijing has given the approval as it braces for greater transmission risks over the winter. No detailed efficacy data of the vaccine has been publicly released. But the vaccine developer, ‘Beijing Biological Products Institute’, a unit of Sinopharm subsidiary China National Biotec Group (CNBG), said Wednesday its vaccine was 79.34% effective in preventing people from developing the disease based on interim data. Approval announced The approval was...
